Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;8(1):5-11.
doi: 10.21037/tau.2018.09.11.

Epidemiology, aetiology and screening of bladder cancer

Affiliations
Review

Epidemiology, aetiology and screening of bladder cancer

Marcus G K Cumberbatch et al. Transl Androl Urol. 2019 Feb.

Abstract

Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease is paramount to improving disease prevention and increasing public awareness. Historically BC has been a disease of industrialized regions and the most responsible carcinogens are tobacco smoke and occupational chemical exposure. BC incidence and mortality differ dramatically by region and reflect differences in risk factor exposure, healthcare behaviour, and population demographics. Screening studies have suggested a survival benefit amongst screened non-symptomatic populations with known risk factors, but this has not become standard practice.

Keywords: Epidemiology; aetiology; bladder; cancer; screening.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
International variation in estimated age-standardised bladder cancer incidence rates (A) in men; (B) in women (2). Age-standardised rates (World Standard Population) per 100,000.

References

    1. Antoni S, Ferlay J, Soerjomataram I, et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol 2017;71:96-108. 10.1016/j.eururo.2016.06.010 - DOI - PubMed
    1. Ferlay J. GLOBOCAN 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012 (online).
    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2018. CA Cancer J Clin 2018;68:7-30. 10.3322/caac.21442 - DOI - PubMed
    1. Dobruch J, Daneshmand S, Fisch M, et al. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol 2016;69:300-10. 10.1016/j.eururo.2015.08.037 - DOI - PubMed
    1. Mungan NA, Kiemeney LA, van Dijck JA, et al. Gender differences in stage distribution of bladder cancer. Urology 2000;55:368-71. 10.1016/S0090-4295(99)00481-1 - DOI - PubMed